Editorial: Interstitial Lung Disease Around the World by Marlies Wijsenbeek, Joyce S. Lee, Zarir Udwadia, Michael Kreuter, Michael Kreuter

Get full text

Interstitial lung diseases: course report by Michael Kreuter, Diana Calaras

Get full text

The threat in chronic lung diseases: acute exacerbations by Michael Kreuter, Vincent Cottin

Get full text

Management of idiopathic pulmonary fibrosis: selected case reports by Michael Kreuter, Peter Kardos, Victor Hoffstein

Get full text

Where are the gaps in education in the field of rare lung disease? Perspectives from the ERN-LUNG educational programme survey by Pippa Powell, Michael Kreuter, Marlies Wijsenbeek-Lourens

Get full text

Interstitial lung diseases: course report by Michael Kreuter, Athol Wells, Deval R. Mehta, Anna Kovchun

Get full text

Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials by Michael Kreuter, Harald Koegler, Matthias Trampisch, Silke Geier, Luca Richeldi

Get full text

Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management by Fabrizio Luppi, Meena Kalluri, Paola Faverio, Michael Kreuter, Giovanni Ferrara

Get full text

Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis by Larissa Schwarzkopf, Sabine Witt, Julia Waelscher, Markus Polke, Michael Kreuter

Get full text

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis by Thomas Skovhus Prior, Julia Wälscher, Benjamin Gross, Elisabeth Bendstrup, Michael Kreuter

Get full text

Thoracic surgery in the non-intubated spontaneously breathing patient by Matthias Grott, Martin Eichhorn, Florian Eichhorn, Werner Schmidt, Michael Kreuter, Hauke Winter

Get full text

Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study by Pavo Marijic, Larissa Schwarzkopf, Lars Schwettmann, Thomas Ruhnke, Franziska Trudzinski, Michael Kreuter

Get full text

Comparing outcomes of ILD patients managed in specialised versus non-specialised centres by Pavo Marijic, Larissa Schwarzkopf, Werner Maier, Franziska Trudzinski, Michael Kreuter, Lars Schwettmann

Get full text

Is the internet a sufficient source of information on sarcoidosis? by Katharina Buschulte, Philipp Höger, Claudia Ganter, Marlies Wijsenbeek, Nicolas Kahn, Katharina Kriegsmann, Finn M. Wilkens, Jolene H. Fisher, Christopher J. Ryerson, Felix J. F. Herth, Michael Kreuter, Michael Kreuter

Get full text

The therapy of idiopathic pulmonary fibrosis: what is next? by Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, Nicolas Kahn, Veronika Müller, Michael Kreuter

Get full text

Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions by Giovanni Ferrara, Fabrizio Luppi, Surinder S. Birring, Stefania Cerri, Antonella Caminati, Magnus Sköld, Michael Kreuter

Get full text

Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era by Gizal Nakshbandi, Catharina C. Moor, Kerri A. Johannson, Toby M. Maher, Michael Kreuter, Marlies S. Wijsenbeek

Get full text

Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases by Colin Holtze, Kevin Flaherty, Michael Kreuter, Fabrizio Luppi, Teng Moua, Carlo Vancheri, Mary B. Scholand

Get full text

Cost drivers in the pharmacological treatment of interstitial lung disease by Phillen Nozibuyiso Maqhuzu, Michael Kreuter, Thomas Bahmer, Nicolas Kahn, Martin Claussen, Rolf Holle, Larissa Schwarzkopf

Get full text

Efficacy, safety, and tolerability of combined pirfenidone and N-acetylcysteine therapy: a systematic review and meta-analysis by Hanyu Shi, Dawei Yin, Francesco Bonella, Michael Kreuter, Ute Oltmanns, Xuren Li, Shouchun Peng, Luqing Wei

Get full text